Avenir Müller Hip Stem Post Market Surveillance Study

Rheumatoid Arthritis Clinical Trial

Official title: A Multi-centre, Non-comparative, Retrospective Post-market Surveillance Study to Obtain Clinical Outcomes Data on the Zimmer Avenir Müller Hip Stem

Status Completed

Clinical Trial Summary

This study is a Post Market Clinical Follow up study to fulfil the post market surveillance obligations according to Medical Device Directive and European Medical Device Vigilance System (MEDDEV) 2.12-2. The data collected from this study will serve the purpose of confirming safety and performance of the Avenir Müller Hip Stem.

Clinical Trial Description

The objective of this post market surveillance study is to obtain outcome data on the Avenir Müller Hip Stem by analysis of standard scoring systems, radiographs and adverse event records, and thus to assess the long-term performance and safety of this implant. This is a multi-centre, retrospective post-market surveillance study involving orthopaedic surgeons skilled in hip surgery. Each case enrolled has received the Avenir Müller Hip Stem for a primary hip arthroplasty. The Avenir Müller Hip Stem is CE marked (European Conformity) and commercially available. ;

Related Conditions & MeSH terms

• Dislocated Hip
• Fracture of Hip
• Hip Fractures
• Joint Diseases
• Osteoarthritis, Hip
• Osteonecrosis
• Post-traumatic; Arthrosis
• Rheumatoid Arthritis
• Subluxation Hip

• NCT number: NCT04079127
• Study type: Observational
• Source: Zimmer Biomet
• Status: Completed
• Start date: January 9, 2010
• Completion date: August 31, 2019